Is this FDA enforcement data for Teva Pharmaceuticals USA, Inc official?

Every record links directly to its primary FDA.gov source. Argus HQ aggregates and structures public FDA data; the verbatim FDA record is always the source of truth.

How many FDA actions has Teva Pharmaceuticals USA, Inc had?

Argus HQ has recorded 7 FDA events for Teva Pharmaceuticals USA, Inc: 0 warning letters, 7 recalls, 0 approvals, and 0 Form 483 inspection observations. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

What is the most recent FDA action against Teva Pharmaceuticals USA, Inc?

The most recent FDA event Argus HQ has on file for Teva Pharmaceuticals USA, Inc is dated 2026-05-13, with a severity rating of "high" in Argus HQ's classification. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Does Argus HQ track new FDA actions for Teva Pharmaceuticals USA, Inc automatically?

Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to Teva Pharmaceuticals USA, Inc is observed, this page's event count and history update automatically.

Teva Pharmaceuticals USA, Inc's Complete FDA Record

FDA action counts

Total FDA actions	9
Warning letters	0
Recalls	7
Approval records	2
Form 483 inspection citations	0
Most recent action	June 26, 2026

Key takeaway: Argus HQ has recorded 7 FDA events for Teva Pharmaceuticals USA, Inc: 0 warning letters, 7 recalls, 0 approvals, and 0 inspection 483 observations. These events span from 2026-04-15 to 2026-05-13. The most severe rating Argus HQ has assigned across this history is "high". Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

Enforcement history

On 2026-04-15, Argus HQ recorded a FDA recall for Teva Pharmaceuticals USA, Inc, rated "high" severity in Argus HQ's classification: Teva Pharmaceuticals USA, Inc — Class II recall: Clonidine Transdermal System, USP, 0.2 mg/day, supplied in cartons of 4 Systems… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-04-15, Argus HQ recorded a FDA recall for Teva Pharmaceuticals USA, Inc, rated "high" severity in Argus HQ's classification: Teva Pharmaceuticals USA, Inc — Class II recall: Clonidine Transdermal System, USP, 0.1 mg/day, supplied in cartons of 4 Systems… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-04-15, Argus HQ recorded a FDA recall for Teva Pharmaceuticals USA, Inc, rated "high" severity in Argus HQ's classification: Teva Pharmaceuticals USA, Inc — Class II recall: Clonidine Transdermal System, USP, 0.3 mg/day, supplied in cartons of 4 Systems… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-04-15, Argus HQ recorded a FDA recall for Teva Pharmaceuticals USA, Inc, rated "high" severity in Argus HQ's classification: Teva Pharmaceuticals USA, Inc — Class II recall: Isotretinoin Capsules, USP, 40 mg, 10 count Prescription Pacs, Rx only, Manufact… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-04-15, Argus HQ recorded a FDA recall for Teva Pharmaceuticals USA, Inc, rated "high" severity in Argus HQ's classification: Teva Pharmaceuticals USA, Inc — Class II recall: Isotretinoin Capsules, USP, 30 mg, Rx Only, 10 count Prescription Pack, Manufact… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-04-29, Argus HQ recorded a FDA recall for Teva Pharmaceuticals USA, Inc, rated "high" severity in Argus HQ's classification: Teva Pharmaceuticals USA, Inc — Class II recall: Claravis (isotretinoin capsule, USP), 10 mg, Packaged as a) 100-count carton, ND… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-05-13, Argus HQ recorded a FDA recall for Teva Pharmaceuticals USA, Inc, rated "high" severity in Argus HQ's classification: Teva Pharmaceuticals USA, Inc — Class II recall: Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 30… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. In total, Teva Pharmaceuticals USA, Inc has 7 FDA events on file with Argus HQ across the sources Argus HQ currently tracks (FDA Warning Letters, recalls, drug/biologic approvals, and Form 483 inspection observations).

Risk pattern analysis

Argus HQ analysis — not an FDA finding

This section is Argus HQ analysis, not an FDA finding. Teva Pharmaceuticals USA, Inc has 7 separate FDA recalls on file, more than a single isolated recall event. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

Frequently asked questions

Is this FDA enforcement data for Teva Pharmaceuticals USA, Inc official?: Every record links directly to its primary FDA.gov source. Argus HQ aggregates and structures public FDA data; the verbatim FDA record is always the source of truth.
How many FDA actions has Teva Pharmaceuticals USA, Inc had?: Argus HQ has recorded 7 FDA events for Teva Pharmaceuticals USA, Inc: 0 warning letters, 7 recalls, 0 approvals, and 0 Form 483 inspection observations. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
What is the most recent FDA action against Teva Pharmaceuticals USA, Inc?: The most recent FDA event Argus HQ has on file for Teva Pharmaceuticals USA, Inc is dated 2026-05-13, with a severity rating of "high" in Argus HQ's classification. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
Does Argus HQ track new FDA actions for Teva Pharmaceuticals USA, Inc automatically?: Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to Teva Pharmaceuticals USA, Inc is observed, this page's event count and history update automatically.

Every FDA action tied to this company, the week it happens.

Free weekly briefing. Real-time alerts on paid plans.

Compare with

Two different companies merged onto this page by mistake? Or a name variant missing? Tell us — corrections@argushq.ai

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA

Argus HQ Research (2026). Teva Pharmaceuticals USA, Inc's Complete FDA Record. Digital Empire LLC. Retrieved from https://argushq.ai/company/teva-pharmaceuticals-usa-inc

MLA

"Teva Pharmaceuticals USA, Inc's Complete FDA Record." Argus HQ Research, Digital Empire LLC, 2026, argushq.ai/company/teva-pharmaceuticals-usa-inc.

Chicago

Argus HQ Research. "Teva Pharmaceuticals USA, Inc's Complete FDA Record." Digital Empire LLC. Accessed July 13, 2026. https://argushq.ai/company/teva-pharmaceuticals-usa-inc.

BibTeX

@misc{argushq_argushq_ai_company_teva_pharmaceuticals_usa_inc_2026,
  title = {Teva Pharmaceuticals USA, Inc's Complete FDA Record},
  author = {{Argus HQ Research}},
  year = {2026},
  publisher = {Digital Empire LLC},
  url = {https://argushq.ai/company/teva-pharmaceuticals-usa-inc},
  note = {Accessed: July 13, 2026}
}

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗